Impedimed Ltd (ASX: IPD) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

Impedimed Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $107.29 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 2.02 billion
Earnings per share -0.010
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

  • Should you invest $1,000 in Impedimed Limited right now?

    Before you buy Impedimed Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Impedimed Limited wasn't one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys...

    See The 5 Stocks *Returns as of 5 December 2024

  • Impedimed Ltd (ASX: IPD)
    Latest News

    a woman
    Investing

    Why the shares of biotech star Impedimed Limited are rocketing today

    Is biotech star Impedimed Limited (ASX:IPD) a buy after today’s positive announcement?

    Read more »

    a woman
    Investing

    3 explosive healthcare shares to give your portfolio a boost

    Impedimed Limited (ASX:IPD) and two other shares could have bright futures ahead of them. Is it time you invested?

    Read more »

    a woman
    Investing

    Beat the market with these 3 growing healthcare shares

    Monash IVF Group Ltd (ASX:MVF) is one of three growing healthcare shares which I believe will beat the market.

    Read more »

    Investing

    Here's why these 4 ASX shares are storming higher today

    The S&P/ASX 200 (Index:^AXJO) (ASX:XJO) may have dropped lower, but that hasn’t stopped Automotive Holdings Group Ltd (ASX:AHG) and three…

    Read more »

    a woman
    Investing

    Here's why the shares of biotech Impedimed Limited are soaring today

    Medical device maker Impedimed Limited (ASX:IPD) has seen its share price soar after launching its first health and wellness product.…

    Read more »

    a woman
    Investing

    Why these 4 ASX shares are soaring today

    Another strong performance for the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) has been made possible thanks to South32 Ltd (ASX:S32) and three…

    Read more »

    a woman
    Investing

    Does biotech Impedimed Limited have blockbuster potential?

    Impedimed Limited (ASX:IPD) to benefit from a 13.1% increase in US reimbursement rates

    Read more »

    a woman
    Investing

    Here's why these 4 shares crashed on the market today

    Could there be worse to come for Myer Holdings Ltd (ASX:MYR), Lifehealthcare Group Ltd (ASX:LHC), Impedimed Limited (ASX:IPD), and Adacel…

    Read more »

    a woman
    Investing

    Watch the Fed: rising US rates will support these Australian blue chips

    All eyes will be on the Fed tomorrow but regardless of the timing of a US rate rise, the environment…

    Read more »

    a woman
    Investing

    Is this company the next Nanosonics Ltd. or Impedimed Limited?

    AtCor Medical Holdings Limited (ASX:ACG) is well placed to follow in the footsteps as sector stars Nanosonics Ltd. (ASX:NAN) and…

    Read more »

    a woman
    Investing

    10 S&P/ASX 300 stocks every investor needs on their watchlist

    The S&P/ASX300 (ASX:XKO) (Index:^AXKO) index has just added a heap of promising growth stocks which you need to know.

    Read more »

    a woman
    Investing

    Two small cap stocks I am banking on in 2015

    Our sharemarket has posted a solid start to the year but there are two small cap stocks I am counting…

    Read more »

    Frequently Asked Questions

    IPD ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Impedimed Ltd

    Impedimed Ltd (ASX: IPD) is a global leader in the design and manufacture of medical devices that use bioimpedance spectroscopy (BIS) technologies in the non-invasive clinical assessment of fluid and tissue composition.

    The company's products are typically used to assess and monitor lymphedema and heart failure, as well as to measure patients' tissue composition and fluid status. They also have general health applications in weight management, nutritional issues, and assessing bone content.

    As well, Impedimed offers a cloud-based digital platform to manage patient data. The company is based in Australia and generates most of its revenue in North America. 

    IPD Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    03 Jan 2025 $0.05 $0.00 0.00% 82,554 $0.05 $0.05 $0.05
    31 Dec 2024 $0.05 $0.00 0.00% 265,143 $0.05 $0.05 $0.05
    30 Dec 2024 $0.05 $0.00 0.00% 502,054 $0.05 $0.05 $0.05
    27 Dec 2024 $0.05 $0.00 0.00% 543,922 $0.05 $0.05 $0.05
    24 Dec 2024 $0.05 $0.00 0.00% 11,722 $0.05 $0.05 $0.05
    23 Dec 2024 $0.05 $0.00 0.00% 926,360 $0.05 $0.05 $0.05
    20 Dec 2024 $0.05 $0.00 0.00% 847,215 $0.05 $0.05 $0.05
    19 Dec 2024 $0.05 $0.00 0.00% 951,141 $0.05 $0.05 $0.05
    18 Dec 2024 $0.05 $0.00 0.00% 3,056,325 $0.05 $0.05 $0.05
    17 Dec 2024 $0.05 $0.00 0.00% 1,353,280 $0.05 $0.05 $0.05
    16 Dec 2024 $0.05 $0.00 0.00% 747,191 $0.05 $0.05 $0.05
    13 Dec 2024 $0.06 $0.00 0.00% 920,650 $0.06 $0.06 $0.05
    12 Dec 2024 $0.06 $0.00 0.00% 573,379 $0.06 $0.06 $0.06
    11 Dec 2024 $0.06 $0.00 0.00% 502,896 $0.06 $0.06 $0.06
    10 Dec 2024 $0.06 $0.00 0.00% 334,026 $0.06 $0.06 $0.06
    09 Dec 2024 $0.06 $0.00 0.00% 4,046,474 $0.05 $0.06 $0.05
    06 Dec 2024 $0.05 $0.00 0.00% 544,126 $0.05 $0.05 $0.05
    05 Dec 2024 $0.05 $0.00 0.00% 255,523 $0.05 $0.05 $0.05

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    23 Dec 2024 Andrew Grant Issued 152,468 $8,400
    Director remuneration.
    23 Dec 2024 Christine Emmanuel-Donnelly Issued 269,542 $14,851
    Director remuneration.
    22 Nov 2024 Christine Emmanuel-Donnelly Buy 295,000 $15,915
    On-market trade.
    05 Sep 2024 Andrew Grant Buy 600,000 $28,530
    On-market trade.
    30 Aug 2024 Andrew Grant Buy 1,000,000 $49,600
    On-market trade.
    30 Aug 2024 Christine Emmanuel-Donnelly Buy 200,000 $10,000
    On-market trade.
    14 May 2024 Christine Emmanuel-Donnelly Buy 100,000 $8,000
    On-market trade.
    06 May 2024 Andrew Grant Buy 100,000 $8,050
    On-market trade.
    29 Feb 2024 Andrew Grant Buy 100,000 $87,000
    On-market trade.
    28 Feb 2024 Andrew Grant Buy 130,000 $10,920
    On-market trade.
    28 Feb 2024 Christine Emmanuel-Donnelly Buy 121,952 $10,169
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Christine Emmanuel-Donnelly Non-Executive Director Sep 2023
    Ms Emmanuel-Donnelly brings 30 years in IP expertise through commercialisation and strategic in-house intellectual property roles. She has more than 4 years in Board and healthcare governance experience. She is a member of the Risk Committee.
    Steven Chen Chief Medical Officer
    -
    Ashley Munoz Director Human Resources
    -
    Andrew Grant Executive Director VP Product Development & Customer Solutions
    -
    Julie Kuhlken Senior Director Downstream Marketing
    -
    Dennis Schlaht SVP R&D and Technology
    -
    Tim Benkovic SVP Sales & Customer Success
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Citicorp Nominees Pty Limited 177,180,440 8.76%
    HSBC Custody Nominees (Australia) Limited 164,419,200 8.13%
    Jp Morgan Nominees Australia Pty Limited 148,941,253 7.36%
    National Nominees Limited 115,304,879 5.70%
    HSBC Custody Nominees (Australia) Limited i 55,570,348 2.75%
    BNP Paribas Noms Pty Ltd 34,426,377 1.70%
    Sunlora Pty Ltd 32,125,000 1.59%
    Moore Family Nominee Pty Ltd 30,000,000 1.48%
    Mr Hamish Alexander Jones 23,538,705 1.16%
    Mba Investments Pty Ltd 22,490,990 1.11%
    Mr Gregory Wayne Brown 20,300,000 1.00%
    Mr Stephen Edward Mahnken & Mrs Dior Leone Mahnken 19,000,000 0.94%
    Bnp Paribas Nominees Pty Ltd i 18,925,694 0.94%
    Pakasoluto Pty Limited 16,011,422 0.79%
    Mr Hsien Michael Soo 15,662,797 0.77%
    First Samuel Ltd Acn 086243567 15,281,508 0.76%
    HSBC Custody Nominees (Australia) Limited A/C 2 14,251,964 0.70%
    Bsd Pty Ltd 13,495,000 0.67%
    Hme Soo Holdings Pty Ltd 12,320,921 0.61%
    Bnp Paribas Nominees Pty Ltd ii 11,693,112 0.58%

    Profile

    since

    Note